Legend Biotech Corporation (LEGN)
NASDAQ: LEGN · Real-Time Price · USD
28.69
+0.26 (0.91%)
At close: Jun 26, 2026, 4:00 PM EDT
29.30
+0.61 (2.13%)
After-hours: Jun 26, 2026, 7:07 PM EDT
Legend Biotech Stock Forecast
Stock Price Forecast
The 12 analysts with 12-month price forecasts for Legend Biotech stock have an average target of 55.79, with a low estimate of 24 and a high estimate of 80. The average target predicts an increase of 94.46% from the current stock price of 28.69.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Legend Biotech stock from 15 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 11 | 9 | 9 | 9 | 8 | 8 |
| Buy | 5 | 5 | 5 | 5 | 5 | 5 |
| Hold | 2 | 2 | 2 | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 18 | 16 | 16 | 16 | 15 | 15 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Goldman Sachs | Goldman Sachs | Buy Maintains $44 → $41 | Buy | Maintains | $44 → $41 | +44.37% | Jun 26, 2026 |
| Oppenheimer | Oppenheimer | Buy Maintains $75 | Buy | Maintains | $75 | +161.42% | Jun 15, 2026 |
| Piper Sandler | Piper Sandler | Buy Reiterates $64 | Buy | Reiterates | $64 | +123.07% | Jun 15, 2026 |
| Barclays | Barclays | Buy Maintains $80 | Buy | Maintains | $80 | +178.84% | Jun 15, 2026 |
| UBS | UBS | Buy Reiterates $31 → $49 | Buy | Reiterates | $31 → $49 | +70.79% | Jun 3, 2026 |
Financial Forecast
Revenue This Year
1.42B
from 1.03B
Increased by 38.41%
Revenue Next Year
1.81B
from 1.42B
Increased by 27.38%
EPS This Year
0.28
from -1.60
EPS Next Year
1.34
from 0.28
Increased by 376.79%
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 1.5B | 2.1B | |
| Avg | 1.4B | 1.8B | |
| Low | 1.4B | 1.5B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 41.6% | 46.0% | |
| Avg | 38.4% | 27.4% | |
| Low | 33.4% | 6.9% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 0.28 | 1.56 | |
| Avg | 0.28 | 1.34 | |
| Low | 0.28 | 1.11 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | 457.1% | |
| Avg | - | 376.8% | |
| Low | - | 296.4% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.